Forte Biosciences, Inc. (FBRX)
USD 18.75
(-4.63%)
USD 18.75
(-4.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 18.03 Million |
| Cost of Revenue | 9000.00 | - | 36 Thousand | 54 Thousand | 11 Thousand | - |
| Gross Profit | -9000.00 | - | -36 Thousand | -54 Thousand | -11 Thousand | 18.03 Million |
| Operating Expenses | 32.47 Million | 13.89 Million | 21.48 Million | 14.22 Million | 4.06 Million | 63.26 Million |
| Selling, General and Administrative Expenses | 10.61 Million | 8.3 Million | 7.63 Million | 4.22 Million | 1.38 Million | 12.8 Million |
| Research and Development Expenses | 21.86 Million | 5.59 Million | 13.85 Million | 10 Million | 2.68 Million | 50.45 Million |
| Other Expenses | -1.00 | 17 Thousand | -222 Thousand | -205 Thousand | -6853.00 | - |
| Cost and Expenses | 32.48 Million | 13.89 Million | 21.48 Million | 14.22 Million | 4.06 Million | 63.88 Million |
| Operating Income | -32.48 Million | -13.89 Million | -21.48 Million | 17.83 Million | -4.06 Million | -45.85 Million |
| Interest Expense | - | - | - | - | - | 173.38 Thousand |
| Income Tax Expense | - | -17 Thousand | -200.55 Thousand | 32.05 Million | -2520.00 | 1.69 Million |
| Earnings before Tax | -31.47 Million | -13.87 Million | -21.7 Million | -46.48 Million | -4.06 Million | -47.25 Million |
| Net Income | -31.47 Million | -13.86 Million | -21.7 Million | -78.54 Million | -4.06 Million | -48.95 Million |
| Earnings Per Share Basic | -24.92 | -19.96 | -38.85 | -157.93 | -48.25 | -915.18 |
| Earnings Per Share Diluted | -24.92 | -19.96 | -38.85 | -157.93 | -48.25 | -915.18 |
| Weighted Average Shares Outstanding | 1.26 Million | 695.34 Thousand | 558.71 Thousand | 294.35 Thousand | 84.33 Thousand | 53.49 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.26 Million | 695.34 Thousand | 558.71 Thousand | 294.35 Thousand | 84.33 Thousand | 53.49 Thousand |
| Gross Margin | - | - | - | - | - | 1.00 |
| EBIT Margin | - | - | - | - | - | -2.51 |
| Profit Margin | - | - | - | - | - | -2.71 |
| EBITDA | -32.47 Million | -13.89 Million | -21.45 Million | -46.43 Million | -4.05 Million | -43.69 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -2.54 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 6000.00 | - | - |
| Cost of Revenue | 10 Thousand | 9000.00 | 9000.00 | 6000.00 | 3000.00 | - |
| Gross Profit | -10 Thousand | -9000.00 | -9000.00 | - | -3000.00 | - |
| Operating Expenses | 12.8 Million | 7.79 Million | 32.47 Million | 6.37 Million | 10.21 Million | 9.03 Million |
| Selling, General and Administrative Expenses | 7.06 Million | 3.44 Million | - | 2.8 Million | 3.84 Million | 1.89 Million |
| Research and Development Expenses | 5.74 Million | 4.35 Million | - | 3.56 Million | 6.36 Million | 7.13 Million |
| Other Expenses | 307 Thousand | 384 Thousand | - | -615 Thousand | 261 Thousand | 138 Thousand |
| Cost and Expenses | 12.81 Million | 7.8 Million | 32.48 Million | 6.38 Million | 10.21 Million | 9.03 Million |
| Operating Income | -12.81 Million | -7.8 Million | -32.48 Million | -6.38 Million | -10.21 Million | -9.03 Million |
| Interest Expense | - | - | - | 102 Thousand | - | - |
| Income Tax Expense | - | -34.27 Thousand | - | 114.03 Thousand | -3000.00 | -9034.00 |
| Earnings before Tax | -12.51 Million | -7.42 Million | -31.47 Million | -5.87 Million | -9.95 Million | -8.89 Million |
| Net Income | -12.51 Million | -7.42 Million | -31.47 Million | -5.87 Million | -9.95 Million | -8.89 Million |
| Earnings Per Share Basic | -0.27 | -0.16 | - | -0.16 | -0.26 | -0.42 |
| Earnings Per Share Diluted | -0.27 | -0.16 | - | -0.16 | -0.26 | -0.42 |
| Weighted Average Shares Outstanding | 46.13 Million | 46.08 Million | 31.57 Million | 36.33 Million | 37.86 Million | 21.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 46.13 Million | 46.08 Million | 31.57 Million | 36.33 Million | 37.86 Million | 21.04 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | -1062.50 | - | - |
| Profit Margin | - | - | - | -978.67 | - | - |
| EBITDA | -12.8 Million | -7.79 Million | - | -6.37 Million | -10.21 Million | -9.03 Million |
| Earnings Before Tax Margin | - | - | - | -1063.50 | - | - |
MKG
MARK
HBT
CPL
000025
WLRMF